199 related articles for article (PubMed ID: 19439356)
1. A critical evaluation of the cost-effectiveness of radon protection methods in new homes in a radon affected area of England.
Coskeran T; Denman A; Phillips P; Tornberg R
Environ Int; 2009 Aug; 35(6):943-51. PubMed ID: 19439356
[TBL] [Abstract][Full Text] [Related]
2. A cost-effectiveness analysis of radon protection methods in domestic properties: a comparative case study in Brixworth, Northamptonshire, UK.
Coskeran T; Denman A; Phillips P; Tornberg R
J Environ Radioact; 2006; 91(1-2):73-89. PubMed ID: 17027126
[TBL] [Abstract][Full Text] [Related]
3. A new methodology for cost-effectiveness studies of domestic radon remediation programmes: quality-adjusted life-years gained within primary care trusts in central England.
Coskeran T; Denman A; Phillips P; Gillmore G; Tornberg R
Sci Total Environ; 2006 Jul; 366(1):32-46. PubMed ID: 16574198
[TBL] [Abstract][Full Text] [Related]
4. The cost-effectiveness of radon-proof membranes in new homes: a case study from Brixworth, Northamptonshire, UK.
Coskeran T; Denman A; Phillips P; Tornberg R
Health Policy; 2007 May; 81(2-3):195-206. PubMed ID: 16854498
[TBL] [Abstract][Full Text] [Related]
5. A cost-effectiveness analysis of domestic radon remediation in four primary care trusts located in Northamptonshire, UK.
Coskeran T; Denman A; Phillips P; Tornberg R
Health Policy; 2005 Jan; 71(1):43-56. PubMed ID: 15563992
[TBL] [Abstract][Full Text] [Related]
6. An assessment of the effectiveness of UK building regulations for new homes in Radon Affected Areas.
Denman AR; Crockett RGM; Groves-Kirkby CJ
J Environ Radioact; 2018 Dec; 192():166-171. PubMed ID: 29982000
[TBL] [Abstract][Full Text] [Related]
7. Lung-cancer reduction from smoking cessation and radon remediation: a preliminary cost-analysis in Northamptonshire, UK.
Groves-Kirkby CJ; Timson K; Shield G; Denman AR; Rogers S; Phillips PS
Environ Int; 2011 Feb; 37(2):375-82. PubMed ID: 21109305
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness of radon preventive and remedial measures in Irish homes.
Long S; Fenton D; Cremin M; Morgan A
J Radiol Prot; 2013 Mar; 33(1):141-9. PubMed ID: 23295191
[TBL] [Abstract][Full Text] [Related]
9. Characterization and control of radon-222 and its progeny in buildings.
Maher EF
Aviat Space Environ Med; 1988 Nov; 59(11 Pt 2):A93-9. PubMed ID: 3202810
[TBL] [Abstract][Full Text] [Related]
10. The cost effectiveness of radon reduction programmes in domestic housing in England and Wales: the impact of improved radon mapping and housing trends.
Denman AR; Sinclair J; Phillips PS; Crockett RG; Groves-Kirkby CJ
Environ Int; 2013 Sep; 59():73-85. PubMed ID: 23792416
[TBL] [Abstract][Full Text] [Related]
11. Application of the advanced radon diagnosis methods in the indoor building environment.
Fronka A; Moucka L; Cechák T
Radiat Prot Dosimetry; 2008; 130(1):72-5. PubMed ID: 18390535
[TBL] [Abstract][Full Text] [Related]
12. The cost effectiveness of radon remediation programmes in hospitals, schools and homes in radon affected areas in the UK.
Denman AR; Phillips PS; Tornberg R
Sci Total Environ; 2001 May; 272(1-3):23-4. PubMed ID: 11379914
[No Abstract] [Full Text] [Related]
13. Cost-effectiveness of countermeasures against radon in the Czech Republic: preliminary report.
Thomas J; Tomasek L; Fojtíková I; Bernovsky P
Radiat Prot Dosimetry; 2008; 130(1):18-21. PubMed ID: 18420563
[TBL] [Abstract][Full Text] [Related]
14. Residential radon in Canada: an uncertainty analysis of population and individual lung cancer risk.
Brand KP; Zielinski JM; Krewski D
Risk Anal; 2005 Apr; 25(2):253-69. PubMed ID: 15876202
[TBL] [Abstract][Full Text] [Related]
15. Cost-benefit analyses of radon mitigation projects.
Petersen ML; Larsen T
J Environ Manage; 2006 Oct; 81(1):19-26. PubMed ID: 16616412
[TBL] [Abstract][Full Text] [Related]
16. Work to save dose: contrasting effective dose rates from radon exposure in workplaces and residences against the backdrop of public and occupational regulatory limits.
Whicker JJ; McNaughton MW
Health Phys; 2009 Sep; 97(3):248-56. PubMed ID: 19667808
[TBL] [Abstract][Full Text] [Related]
17. An overview of Ireland's National Radon Policy.
Long S; Fenton D
Radiat Prot Dosimetry; 2011 May; 145(2-3):96-100. PubMed ID: 21459876
[TBL] [Abstract][Full Text] [Related]
18. Evaluation and equity audit of the domestic radon programme in England.
Zhang W; Chow Y; Meara J; Green M
Health Policy; 2011 Sep; 102(1):81-8. PubMed ID: 21030106
[TBL] [Abstract][Full Text] [Related]
19. Revealed preference valuation compared to contingent valuation: radon-induced lung cancer prevention.
Kennedy CA
Health Econ; 2002 Oct; 11(7):585-98. PubMed ID: 12369061
[TBL] [Abstract][Full Text] [Related]
20. A review of the cost effectiveness of radon mitigation in domestic properties in Northamptonshire.
Denman AR; Phillips PS
J Radiol Prot; 1998 Jun; 18(2):119-24. PubMed ID: 9656192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
